Department of Biochemistry and Molecular Biology, Faculty of Optics and Optometry, Universidad Complutense de Madrid, Madrid, Spain.
Department of Biochemistry and Molecular Biology, Faculty of Optics and Optometry, Universidad Complutense de Madrid, Madrid, Spain.
Exp Eye Res. 2022 Nov;224:109245. doi: 10.1016/j.exer.2022.109245. Epub 2022 Sep 7.
Osmotic stress is an important challenge to cell function. Dry eye pathology is characterized by elevated tear film osmolarity as consequence of decreased tear secretion and/or increased evaporation. Dry eye pathogenesis is not completely clarified. However, it is known that tear hyperosmolarity induces NLRP3 (nucleotide-binding oligomerization domain-like receptor family, pyrin domain-cointaining 3) inflammasome activation and inflammatory mediators release that leads to ocular surface damage. Annexin A1 is a protein involved in anti-inflammatory or pro-resolution actions in different tissues while its presence and biological role on ocular surface has been scarcely examined. In this study, potential changes in annexin A1 protein expression and secretion on the ocular surface after exposure to hyperosmolar conditions were evaluated. In addition, considering the significant role of inflammation in dry eye pathology, the potential anti-inflammatory activity of Ac2-26, an annexin A1 peptide mimicking its N-terminus, was assessed. Cytosolic and membrane staining was detected for annexin A1 in corneal and conjunctival epithelial cells. A native form of annexin A1 together with a truncated form were detected by western blot analysis. Under hyperosmotic conditions increased protein levels of intracellular and secreted annexin A1 as well as higher expression of its receptor Fpr2 (formyl peptide receptor type 2) were found. Treatment with mimetic peptide Ac2-26 ameliorated NLRP3 activation and interleukin 1β (IL-1β) release triggered by elevated osmolarity in corneal and conjunctival epithelial cells. These findings suggest a potential role of annexin A1 and its mimetic peptide modulating key inflammatory events associated to dry eye.
渗透胁迫是细胞功能的一个重要挑战。干眼症的病理特征是泪膜渗透压升高,这是由于泪液分泌减少和/或蒸发增加所致。干眼症的发病机制尚未完全阐明。然而,已知泪液高渗会诱导 NLRP3(核苷酸结合寡聚化结构域样受体家族,含pyrin 结构域的 3)炎症小体的激活和炎症介质的释放,从而导致眼表面损伤。膜联蛋白 A1 是一种在不同组织中参与抗炎或促解决反应的蛋白质,而其在眼表面的存在和生物学作用尚未得到充分研究。在这项研究中,评估了在高渗条件下暴露后眼表面膜联蛋白 A1 蛋白表达和分泌的潜在变化。此外,鉴于炎症在干眼症病理中的重要作用,评估了膜联蛋白 A1 肽 Ac2-26(模拟其 N 端的膜联蛋白 A1 肽)的潜在抗炎活性。用细胞溶质和膜染色检测角膜和结膜上皮细胞中的膜联蛋白 A1。用 Western blot 分析检测到膜联蛋白 A1 的天然形式和截断形式。在高渗条件下,发现细胞内和分泌型膜联蛋白 A1 的蛋白水平增加,其受体 Fpr2(甲酰肽受体 2)的表达增加。用模拟肽 Ac2-26 处理可改善角膜和结膜上皮细胞中 NLRP3 的激活和升高渗透压触发的白细胞介素 1β(IL-1β)释放。这些发现表明膜联蛋白 A1 及其模拟肽在调节与干眼症相关的关键炎症事件中可能发挥作用。